Hepion Pharmaceuticals In...

NASDAQ: HEPA · Real-Time Price · USD
0.07
0.01 (22.59%)
At close: Jun 09, 2025, 3:45 PM

Hepion Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-1.55M -4.87M -3.93M -2.85M -11.06M -10.53M -14.08M -13.26M -6.81M -8.55M -19.91M -6.93M -9.73M -9.27M -7.67M -6.06M
Depreciation & Amortization
n/a n/a n/a 30.76K 12.27K 18.5K 18.33K 18.04K 18.48K 17.73K 18.53K 22.73K 23.41K 23.11K 21.41K 18.14K
Stock-Based Compensation
28.63K 28.63K 28.63K 705.77K 150.32K 318.91K -1.06M 1.93M 231.94K 616.84K 162.51K 1.54M 847.52K 1.47M 1.39M 957.87K
Other Working Capital
44.34K 2.24M -1.03M 361.37K -815.28K 477.97K 523.93K 2.48M 1.45M 1.19M 2.79M -4.44M 576.15K -3.26M -1.42M -389.47K
Other Non-Cash Items
321.62K 407.69K -4.53M 3.9M -260K -140K -88.43K 48.43K -80K 80K -90K -324.99K 730.91K 749.99K 810.01K 30K
Deferred Income Tax
n/a n/a n/a n/a 4.1M n/a n/a n/a n/a n/a 1.87M n/a 10.91K n/a n/a n/a
Change in Working Capital
44.34K 1.91M -2.5M -2.14M -1.94M -906.71K 2.77M 3.05M 1.84M -4.7M 10.45M -4.44M 748.87K -4.3M 271.1K -2.29M
Operating Cash Flow
-1.15M -2.52M -10.93M -3.62M -9M -11.24M -12.44M -8.21M -4.8M -12.53M -7.5M -10.13M -7.38M -11.32M -5.17M -7.35M
Capital Expenditures
n/a n/a n/a n/a -348 2.58K -16.54K n/a -16.34K n/a n/a n/a n/a -36.49K -11.81K -82.11K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 2.27K n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a -600K n/a n/a n/a n/a n/a n/a n/a n/a 2.27 n/a n/a n/a n/a n/a
Investing Cash Flow
n/a -600K n/a n/a -348 2.58K -16.54K n/a -16.34K n/a 2.27K n/a n/a -36.49K -11.81K -82.11K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a -1K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a 2.5M n/a 1.85M 4.49M n/a n/a n/a -3.14M n/a n/a -2M n/a n/a -176.59K n/a
Financial Cash Flow
n/a 2.5M n/a 1.85M 4.49M n/a n/a n/a -3.14M n/a n/a -2M n/a n/a -176.59K 82.15M
Net Cash Flow
-1.09M -617.94K -10.99M -1.68M -4.5M -11.24M -12.47M -8.2M -7.96M -12.56M -7.52M -12.13M -7.38M -11.36M -5.36M 74.72M
Free Cash Flow
-1.15M -2.52M -10.93M -3.62M -9M -11.23M -12.45M -8.21M -4.81M -12.53M -7.5M -10.13M -7.38M -11.36M -5.18M -7.43M